Reclaiming the 3-hour chart review: How AI is solving the complex case bottleneck

Before I started building technology for medicine, I spent years building artificial intelligence (AI) systems for some of the most data-intensive environments in the world. At Google, at Reddit, at Change.org. The problems were different in every case, but the underlying challenge was always the same. How do you help a human being make sense of more information than any human being can reasonably hold in their head at once?

When I turned that lens on health care, I expected to find a technology problem. What I found was a human one.

Physicians are not struggling because they lack access to data or training. They are struggling because the volume and complexity of data their patients now generate has outpaced every system designed to help them act on it. A patient arrives with a two-inch stack of lab results, a genetic panel, a microbiome report and six months of wearable data. The case is chronic, complex and doesn't fit a clean diagnostic category. The patient's physician, who has 15 minutes scheduled and a waiting room full of patients, faces a choice: spend two to three hours of uncompensated time manually cross-referencing patient data to find a pattern, or treat the obvious symptoms and move on.

Most physicians move on. Not because they don't care, but because the system gives them no other viable option. Doctors have shared with me that the amount of time it takes to go over complex patient data frequently takes them hours. For an independent practice already operating on thin margins, the time simply doesn't exist in the schedule.

This is the bottleneck nobody is talking about loudly enough. The conversation around AI in medicine has focused almost entirely on documentation: ambient listening tools, AI scribes, systems that transcribe patient encounters and auto-populate charts. These tools are useful. They save time on paperwork. But they do nothing to help a physician untangle a complex chronic case. They don't synthesize biomarkers. They don't surface patterns across metabolic pathways and genetic variants. They don't tell a physician why a patient whose labs look normal has been symptomatic for three years.

To actually move the needle on physician burnout, health care technology has to move beyond transcription and into clinical reasoning.

The problem is that most AI tools currently marketed to clinicians can't do that reliably. Standard large language models pattern-match against the text they were trained on. They predict what a plausible clinical statement looks like, and at times work with AI conclusions that, while clinically plausible, are not grounded in step-by-step reasoning. Standard generative AI introduces hallucination risk into every output, and in a clinical setting, that risk is not acceptable, an issue that many physicians identify as a central problem when working with AI. The whole idea is, "how can we actually analyze and prevent disease sooner before it becomes a disease?" And the answer is by providing multi-omic analysis with transparent reasoning that allows clinicians to see the links between genetics, the patient's microbiome and labs as openly and cleanly as possible.

I think of patient data like a tree, with countless branches and roots all connected. You're waiting to see how the tree will develop, what kind of branches it will grow, and the best possible way to show how biological systems interact. Physician skepticism toward AI is not irrational. It is the appropriate response to tools that cannot show the logic behind conclusions.

The alternative is what might be called causal AI: systems that don't just pattern-match but reason transparently across biological mechanisms, grounding every output in peer-reviewed literature and showing the pathway behind every recommendation. For a physician managing a complex chronic case, the difference is significant. Instead of a black box producing a confident-sounding suggestion with no traceable logic, a transparent reasoning system surfaces the specific genetic variants, biomarker interactions and mechanistic pathways driving its conclusions. The physician can interrogate the reasoning, validate it against their own clinical judgment and act on it or push back. The tool supports the decision. It doesn't make it.

Parsing more than 5,000 data points across genomic, metabolic and microbiome inputs is something no human could do manually at the speed and accuracy clinical practice requires. There is, through and through, an infrastructure gap. The data exists, and the biological relationships are documented in the literature, but what's been missing is a system capable of synthesizing them at the point of care, in a format a busy clinician can actually use.

This is where the return on investment (ROI) case for independent practices becomes concrete. A tool that can synthesize a complex patient's multi-omic data into a structured, evidence-cited protocol in the time it currently takes a physician to manually review a single chart improves diagnostic quality and foundationally changes the economics of the practice. Cutting analysis time means physicians can see more patients. A diagnostic reasoning companion means that clinicians can take on more complex cases to provide higher-value services and charge more. Clinicians across the grid can offer services more akin to a top-notch functional or precision medicine doctor in Manhattan, even if they're practicing in a rural area. Complex cases that currently create scheduling bottlenecks become manageable, and strong outcomes based on causal reasoning means that interventions are more precise. The hours lost to uncompensated chart review come back, the outcomes improve and more referrals flow.

More importantly, physicians can return to what they went to medical school to do. Not data management. Not manual cross-referencing of biomarker panels. The human-level work: listening, applying context and judgment, deciding and treating the patient sitting in front of them. It takes empathy, and being willing to use technology to better the world.

AI shouldn't replace clinical judgment. It should protect the conditions that make good clinical judgment possible. Right now, those conditions are eroding. The American Medical Association's 2026 survey of burnout symptoms in the previous year identified that while physicians are burning out at a slower rate than during the pandemic, nearly 1 in 2 have experienced at least one symptom of burnout in the last year. But the survey also showed that optimizing workflows was among the ways to reduce burnout. Right now, physicians are buried under administrative burden and data complexity that no individual clinician was ever designed to manage alone. The technology to change that exists. The question is whether the industry will build it the right way, transparently, causally and in genuine service of the physicians and patients who need it most.

Elena Ikonomovska, Ph.D., is co-founder and CEO of Diadia Health.